Publications Database

Anderson L. T. et al. (1989)

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.

Journal of Autism and Developmental Disorders

19(2), pp. 227-239

Read Abstract (New Window)

Aoki Y. et al. (2014)

Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.

Brain

November, 137(11), pp. 3073-3086.

Read Abstract (New Window)

Appleton R. E. et al. (2011)

Mends: the use of melatonin in children with neuro-developmental disorders and impaired sleep - a randomised, double-blind, placebo-controlled, parallel trial.

Archives of Disease in Childhood

96 A1

Read Abstract (New Window)

Arnold L. E. et al. (2003)

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.

Journal of the American Academy of Child and Adolescent Psychiatry

42(12), pp. 1443-1450

Read Abstract (New Window)

Asadabadi M. et al. (2013)

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Psychopharmacology (Berl)

225(1), pp. 51-59.

Read Abstract (New Window)

Barrett R. P. , Feinstein C. , Hole W. T. (1989)

Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.

American Journal of Mental Retardation

93(6), pp. 644-651

Read Abstract (New Window)

Barthélémy C. et al. (1981)

Behavioral and biological effects of oral magnesium, vitamin B6, and combined magnesium-B6 administration in autistic children.

Magnesium Bulletin

2 pp. 150-153

Bashir S. , Al-Ayadhi L. Y. (2014)

Effect of camel milk on thymus and activation-regulated chemokine (TARC) in autistic children: double blind study.

Pediatric Research

April, 75(4), pp. 559-556.

Read Abstract (New Window)

Beeghly J. et al. (1987)

Fenfluramine treatment of autism: relationship of treatment response to blood levels of fenfluramine and norfenfluramine.

Journal of Autism and Developmental Disorders

17(4), pp. 541-548

Read Abstract (New Window)

Belsito K. M. et al. (2001)

Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.

Journal of Autism and Developmental Disorders

31(2), pp. 175-181

Read Abstract (New Window)

Bertoglio K. et al. (2010)

Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism.

Journal of Alternative and Complementary Medicine

May, 16(5), pp. 555-560

Read Abstract (New Window)

Beversdorf D. Q. et al. (2011)

Effect of propranolol on word fluency in autism.

Cognitive and Behavioral Neurology

24(1), pp. 11-7

Read Abstract (New Window)

Bolman W. M. , Richmond J. (1999)

A double-blind, placebo-controlled crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.

Journal of Autism and Developmental Disorders

29(3), pp. 191-194

Read Abstract (New Window)

Boone K. M. et al. (2017)

Omega-3 and -6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: A randomized controlled trial.

Early Human Development

December, 115 pp. 64-70.

Read Abstract (New Window)

Bouvard M. P. et al. (1995)

Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.

Psychiatry Research

58(3), pp. 191-201

Read Abstract (New Window)

Campbell M. et al. (1978)

A comparison of haloperidol and behavior therapy and their interaction in autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

17(4), pp. 640-655

Read Abstract (New Window)

Campbell M. et al. (1990)

Naltrexone in autistic children: a double-blind and placebo-controlled study.

Psychopharmacology Bulletin

26(1), pp. 130-135

Read Abstract (New Window)

Campbell M. et al. (1982)

The effects of haloperidol on learning and behavior in autistic children.

Journal of Autism and Developmental Disorders

12(2), pp. 167-175

Read Abstract (New Window)

Carey T. et al. (2002)

Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism.

Journal of Autism and Developmental Disorders

32(3), pp. 161-167

Read Abstract (New Window)

Chez M. G. et al. (2003)

Donepezil hydrochloride: a double-blind study in autistic children.

Journal of Pediatric Neurology

1(2), pp. 83-88

Read Full (New Window)